Levanta-se o pano: eis o novo visual da Seleção Portuguesa para a Copa do Mundo.

March 19 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its blockbuster weight-loss drug Wegovy. The ...

Federal regulators greenlit Novo Nordisk’s enhanced 7.2mg Wegovy formulation on Thursday Clinical trials showed participants achieved 20.7% average weight reduction over 72 weeks, compared to ...

Novo Nordisk is dropping its lawsuit against Hims & Hers Health, as it has reached an agreement with the telehealth company. The deal will permit Hims & Hers Health to sell Ozempic and Wegovy on its ...

Novo Nordisk A/S and Viatris Inc.’s Mylan unit asked a Delaware federal court to formalize Mylan’s concession that its generic Wegovy injection infringes Novo’s compound patent, an agreement that ...

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs. The agency told Novo Nordisk it had “serious ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Novo Nordisk NOVO.B-0.87%decrease; red down pointing triangle received a warning from the Food and Drug Administration for failing to report serious suspected side effects in patients who took the ...

Hims & Hers Health has sparred with Novo Nordisk for months over the Danish drugmaker’s refusal to sell weight-loss drugs on its platform, but the bitter feud appears to have reached its end.

Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medication and stop ...

Wegovy maker Novo Nordisk said it is teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company’s platform, bringing an end to a legal dispute between the two ...